4
Changes in Ownership
MYRIAD GENETICS INC Filed Acc 0001219036-21-000010
Chief Scientific Officer sold 83,372 shares at an average $31.96 ($2,664,216)
- Chief Scientific Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LANCHBURY JERRY S · Chief Scientific Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-25 | Exercise or conversion : show line 1 in the form | +21,360 | $19.47 | $415,879 | 287,282 | D |
| 2021-06-25 | Sale : show line 2 in the form | −21,360 | $32.47 | $693,559 | 265,922 | D |
| 2021-06-25 | Exercise or conversion : show line 3 in the form | +28,640 | $19.47 | $557,621 | 294,562 | D |
| 2021-06-25 | Sale : show line 4 in the form | −28,640 | $31.97 | $915,621 | 265,922 | D |
| 2021-06-25 | Sale : show line 5 in the form | −33,372 | $31.61 | $1,055,036 | 232,550 | D |
| Open-market sales · 83,372 sh · avg $31.96 · $2,664,216 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-25 | Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) | −21,360 | 47,280 | D |
| 2021-06-25 | Exercise or conversion : show line 7 in the form Non-Qualified Stock Option (right to buy) | −28,640 | 18,640 | D |
Loading xslF345X03/edgardoc.xml…